The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, marking the first dual-agent eye drop therapy for age-related near-vision decline. Unlike previously approved presbyopia drops that contain…
Researchers have found in a new study that injuries sustained at high elevations are linked to significantly higher odds of developing deep vein thrombosis compared with injuries at low elevations.…
USA: A new randomized clinical trial published in NEJM Evidence suggests that solriamfetol may significantly reduce excessive sleepiness in people working early-morning shifts, a population that has received far less…
USA: A large U.S. cohort study has found that infants exposed in the womb to integrase strand transfer inhibitors (INSTIs)—a key class of antiretroviral medications—showed neurodevelopmental outcomes comparable to those…
Researchers have found in a new study that Paricalcitol produces a stronger and faster reduction in parathyroid hormone levels compared with calcitriol, making it preferable in patients with very high…
And other biotech news brought to you by The Readout
Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure has yet to be detailed
Hip fractures are the most common low‑energy injury affecting older adults and place a large burden on healthcare systems. Vitamin D sufficiency is fundamental to healthy bone turnover, maintenance of…
Beijing: British pharmaceutical group AstraZeneca said Thursday that it would invest USD 15 billion in China through 2030 to expand its medicines manufacturing and research, during a trip by UK…
Chennai: Government doctors affiliated with the Federation of Government Doctors Associations (FOGDA) will launch a non-cooperation movement from January 30, 2026, to intensify their protest over a slew of unmet…